Mineralys Therapeutics (MLYS) Stock Chart & Stock Price History → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free MLYS Stock Alerts $12.91 +0.13 (+1.02%) (As of 03/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Mineralys Therapeutics Stock Price Performance5 Day Performance+0.55%1 Month Performance-12.42%3 Month Performance+50.64%6 Month Performance+38.82%Year-To-Date Performance+50.12%1 Year Performance-13.18% Receive MLYS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> MLYS Stock Chart for Thursday, March, 28, 2024 MLYS Chart by TradingView Mineralys Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/27/2024$12.84$12.78-0.47%$13.53$12.6975,310 shs$634.27 million03/26/2024$12.92$12.84-0.62%$13.06$12.6477,034 shs$637.26 million03/25/2024$12.84$12.92+0.62%$13.24$12.8070,351 shs$641.22 million03/22/2024$13.09$12.84-1.91%$13.12$12.63165,110 shs$527.72 million03/21/2024$13.39$13.09-2.24%$13.73$12.65422,264 shs$538.06 million03/20/2024$13.48$13.39-0.67%$13.86$12.87118,838 shs$550.33 million Get the Latest News and Ratings for MLYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/19/2024$12.61$13.48+6.90%$14.03$12.61187,502 shs$554.03 million03/18/2024$12.69$12.61-0.63%$12.89$12.4283,442 shs$518.27 million03/15/2024$12.60$12.69+0.71%$12.88$12.47211,732 shs$521.56 million03/14/2024$12.59$12.60+0.08%$12.77$12.3878,888 shs$517.86 million03/13/2024$12.86$12.59-2.10%$13.05$12.30376,021 shs$517.45 million03/12/2024$13.26$12.86-3.02%$13.30$12.6998,385 shs$528.61 million03/11/2024$14.10$13.26-5.96%$14.35$13.2283,192 shs$544.99 million03/08/2024$13.98$14.10+0.86%$14.55$13.53216,754 shs$579.51 million03/07/2024$14.00$13.98-0.14%$14.21$13.7674,818 shs$574.65 million03/06/2024$14.60$14.00-4.11%$14.88$13.83233,181 shs$575.40 million03/05/2024$14.99$14.60-2.60%$15.08$14.5878,462 shs$600.06 million03/04/2024$15.34$14.99-2.28%$15.45$14.70138,235 shs$616.09 million03/01/2024$15.38$15.34-0.26%$15.89$15.14207,232 shs$630.47 million02/29/2024$14.74$15.38+4.34%$15.46$14.70106,778 shs$632.12 million02/28/2024$15.99$14.74-7.82%$15.95$14.44181,865 shs$605.81 million02/27/2024$16.15$15.99-0.99%$16.91$15.98219,685 shs$657.19 million02/26/2024$15.88$16.15+1.70%$16.23$15.76163,694 shs$663.77 million02/23/2024$15.66$15.88+1.40%$15.93$15.3363,151 shs$652.67 million02/22/2024$15.25$15.66+2.69%$15.96$15.13202,341 shs$643.70 million02/21/2024$15.30$15.25-0.33%$15.38$14.73109,195 shs$626.78 million02/20/2024$15.48$15.30-1.16%$15.57$15.16146,128 shs$628.83 million02/19/2024$15.48$15.48$15.55$14.53251,500 shs$636.23 million02/16/2024$14.98$15.48+3.34%$15.55$14.53251,417 shs$636.23 million02/15/2024$14.54$14.98+3.03%$15.16$14.47244,781 shs$615.68 million02/14/2024$14.25$14.54+2.04%$14.68$14.30116,047 shs$597.59 million02/13/2024$14.72$14.25-3.19%$14.61$13.81445,725 shs$585.68 million02/12/2024$14.73$14.72-0.07%$15.01$14.70203,893 shs$605.07 million02/09/2024$14.03$14.73+4.99%$15.00$14.04361,145 shs$605.40 million02/08/2024$12.47$14.03+12.51%$15.30$13.961.40 million shs$576.63 million02/07/2024$12.28$12.47+1.55%$12.81$12.18174,744 shs$512.52 million02/06/2024$12.03$12.28+2.08%$12.55$11.4760,031 shs$504.71 million02/05/2024$12.16$12.03-1.07%$12.29$11.4199,516 shs$494.43 million02/02/2024$12.70$12.16-4.25%$13.38$12.06158,613 shs$499.78 million02/01/2024$10.91$12.70+16.41%$12.75$10.97507,688 shs$521.97 million[BUY ALERT] Our #1 A.I. Stock for March (Ad)It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>>01/31/2024$10.85$10.91+0.55%$11.20$10.6697,398 shs$448.40 million01/30/2024$10.94$10.85-0.82%$11.15$10.7559,688 shs$445.94 million01/29/2024$10.30$10.94+6.21%$11.09$9.78134,884 shs$449.63 million01/26/2024$10.64$10.30-3.20%$10.93$10.23172,291 shs$423.33 million01/25/2024$10.01$10.64+6.29%$10.80$10.00135,267 shs$437.30 million01/24/2024$9.45$10.01+5.93%$10.33$9.32138,687 shs$411.41 million01/23/2024$8.95$9.45+5.59%$9.46$8.9886,821 shs$388.40 million01/22/2024$8.77$8.95+2.05%$9.04$8.4879,882 shs$367.85 million01/19/2024$8.27$8.77+6.05%$8.88$8.2887,287 shs$360.45 million01/18/2024$8.71$8.27-5.05%$8.83$7.9589,121 shs$339.90 million01/17/2024$8.68$8.71+0.35%$8.81$8.2779,238 shs$357.98 million01/16/2024$9.30$8.68-6.67%$9.35$8.6097,046 shs$356.75 million01/15/2024$9.30$9.30$9.44$8.9277,900 shs$382.23 million01/12/2024$9.02$9.30+3.10%$9.44$8.9277,918 shs$382.23 million01/11/2024$9.23$9.02-2.28%$9.44$8.9696,125 shs$370.72 million01/10/2024$9.06$9.23+1.88%$9.51$8.96229,947 shs$379.35 million01/09/2024$9.12$9.06-0.66%$9.31$8.9065,436 shs$372.37 million01/08/2024$8.65$9.12+5.43%$9.15$8.4865,488 shs$374.88 million01/05/2024$8.63$8.65+0.23%$8.99$8.47116,742 shs$355.52 million01/04/2024$8.55$8.63+0.94%$8.88$8.5081,550 shs$354.74 million01/03/2024$8.68$8.55-1.50%$8.80$8.5094,475 shs$351.41 million01/02/2024$8.60$8.68+0.93%$9.08$8.49119,828 shs$356.75 million01/01/2024$8.60$8.60$8.75$8.37139,200 shs$353.46 million12/29/2023$8.57$8.60+0.35%$8.75$8.36139,264 shs$353.50 million12/28/2023$8.34$8.57+2.76%$8.72$8.2782,577 shs$352.23 million12/27/2023$8.16$8.34+2.21%$8.40$8.0555,821 shs$342.77 million Related Companies: BMEA Stock Chart GHRS Stock Chart TVTX Stock Chart AEON Stock Chart AVBP Stock Chart ALXO Stock Chart IGMS Stock Chart CMPS Stock Chart SIGA Stock Chart NKTX Stock Chart Receive MLYS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MLYS) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.